Financials
- Market Capitalization 3.89 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-20.4
ratio cours/chiffre d'affaires
184.61
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1463 | DNLI Denali Therapeutics Inc. - Common Stock | 26.48 USD | +3.12% | +2.12% | +21.13% | +63.76% | 4.20 B USD | ||
| 1478 | TNGX Tango Therapeutics, Inc. - Common Stock | 28.36 USD | -8.69% | -6.43% | -9.48% | +358.16% | 4.10 B USD | ||
| 1535 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.48 USD | +0.03% | -0.03% | +0.38% | +48.42% | 3.85 B USD | ||
| 1553 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.97 USD | -1.53% | -7.11% | +12.74% | +73.85% | 3.72 B USD |